Seeking Alpha

Valeant (VRX) has agreed to acquire Medicis (MRX), a provider of dermatological and aesthetic...

Valeant (VRX) has agreed to acquire Medicis (MRX), a provider of dermatological and aesthetic pharmaceutical products, for $2.6B, Valeant said yesterday. The firm's offer of $44/share represents a 39% premium to Medicis' close on Friday. The transaction is the latest in a long list of acquisitions for Valeant, which has secured around 50 deals since Michael Pearson became CEO in 2008. (PR).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|